# Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer

> **NCT01485731** · PHASE1 · COMPLETED · sponsor: **University of Miami** · enrollment: 8 (actual)

## Conditions studied

- Cervical Cancer

## Interventions

- **DRUG:** Nelfinavir
- **DRUG:** Cisplatin
- **RADIATION:** Pelvic External Beam Radiation Therapy
- **RADIATION:** Brachytherapy
- **PROCEDURE:** Pharmacokinetic Sampling
- **PROCEDURE:** Cervical Biopsy
- **PROCEDURE:** Pelvic Examination
- **PROCEDURE:** Pap Smear
- **PROCEDURE:** Audiogram
- **PROCEDURE:** Proctoscopy
- **PROCEDURE:** Cytoscopy
- **PROCEDURE:** Renal Ultrasound
- **PROCEDURE:** CT Scan
- **PROCEDURE:** Whole Body PET/CT Scan

## Key facts

- **NCT ID:** NCT01485731
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2015-02
- **Final completion:** 2015-02
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2015-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01485731

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01485731, "Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT01485731. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*